Biofermin Pharmaceutical Co Cash Flow Statement

4517 ¥2527 8.0 0.3%

12:26am

Conservative, Small Cap, Style Neutral

Market Cap £204.3m

Enterprise Value £91.7m

Revenue £71.6m

Quality

Value

Momentum

StockRank™

To unlock Biofermin Pharmaceutical Co's cashflow statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	JPY	JPY	JPY	JPY	JPY	JPY

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Accounts Payable
Taxes Payable
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Total Cash Dividends Paid
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.